LegalJun 8, 2026, 07:06 AM
RedHill Launches Enforcement of $11M Judgment Against Kukbo
AI Summary
RedHill Biopharma Ltd. has initiated recognition and enforcement proceedings in Korea for an $10.9 million New York Supreme Court final judgment against Kukbo Co. Ltd. The judgment, which includes approximately $8.9 million for the principal award and $1.95 million for legal fees and expenses, became final in November 2025 and March 2026, respectively, with no further appeals possible. RedHill had previously secured a Korean court attachment against Kukbo to prevent asset disposal, and now awaits Kukbo's response in the Korean proceedings.
Key Highlights
- RedHill launched enforcement of an approximately $10.9 million New York Supreme Court final judgment against Kukbo Co. Ltd.
- The judgment includes a main award of approximately $8.9 million.
- An additional award of approximately $1.95 million covers legal fees and expenses.
- The total amount includes 9% statutory interest, which continues to accrue.
- The principal award became final in November 2025, and the legal fees award in March 2026.
- No further appeals are permissible for either judgment.
- RedHill previously secured a Korean court attachment against Kukbo to prevent asset disposal.
Price Impact
More from RDHL